Repurposing and computational design of PARP inhibitors as SARS-CoV-2 inhibitors
Description
Coronavirus disease 2019 (COVID-19) is a recent pandemic that caused serious global emergency. To identify new and effective therapeutics, we employed a drug repurposing approach. The poly (ADP ribose) polymerase inhibitors were used for this purpose
